KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Account Payables (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Change in Account Payables for 11 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 1982.81% year-over-year to $1.3 million, compared with a TTM value of $2.6 million through Dec 2025, up 188.67%, and an annual FY2025 reading of $2.6 million, up 188.67% over the prior year.
  • Change in Account Payables was $1.3 million for Q4 2025 at Medpace Holdings, up from -$10.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $10.7 million in Q1 2025 and bottomed at -$10.7 million in Q3 2025.
  • Average Change in Account Payables over 5 years is $450600.0, with a median of $682500.0 recorded in 2024.
  • The sharpest move saw Change in Account Payables soared 2093.31% in 2022, then plummeted 1761.98% in 2025.
  • Year by year, Change in Account Payables stood at -$284000.0 in 2021, then skyrocketed by 2093.31% to $5.7 million in 2022, then plummeted by 65.17% to $2.0 million in 2023, then tumbled by 96.75% to $64000.0 in 2024, then skyrocketed by 1982.81% to $1.3 million in 2025.
  • Business Quant data shows Change in Account Payables for MEDP at $1.3 million in Q4 2025, -$10.7 million in Q3 2025, and $1.3 million in Q2 2025.